ID PROZ_HUMAN Reviewed; 400 AA. AC P22891; A6NMB4; Q15213; Q5JVF5; Q5JVF6; DT 01-AUG-1991, integrated into UniProtKB/Swiss-Prot. DT 01-NOV-1991, sequence version 2. DT 27-MAR-2024, entry version 228. DE RecName: Full=Vitamin K-dependent protein Z; DE Flags: Precursor; GN Name=PROZ; OS Homo sapiens (Human). OC Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia; OC Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae; OC Homo. OX NCBI_TaxID=9606; RN [1] RP NUCLEOTIDE SEQUENCE [MRNA], GAMMA-CARBOXYGLUTAMATION AT GLU-47; GLU-48; RP GLU-51; GLU-55; GLU-57; GLU-60; GLU-61; GLU-66; GLU-67; GLU-70; GLU-73; RP GLU-75 AND GLU-80, AND PARTIAL PROTEIN SEQUENCE. RC TISSUE=Liver; RX PubMed=2244898; DOI=10.1016/0006-291x(90)91566-b; RA Ichinose A., Takeya H., Espling E., Iwanaga S., Kisiel W., Davie E.W.; RT "Amino acid sequence of human protein Z, a vitamin K-dependent plasma RT glycoprotein."; RL Biochem. Biophys. Res. Commun. 172:1139-1144(1990). RN [2] RP NUCLEOTIDE SEQUENCE [GENOMIC DNA], AND ALTERNATIVE SPLICING. RX PubMed=9578570; DOI=10.1021/bi972002a; RA Fujimaki K., Yamazaki T., Taniwaki M., Ichinose A.; RT "The gene for human protein Z is localized to chromosome 13 at band q34 and RT is coded by eight regular exons and one alternative exon."; RL Biochemistry 37:6838-6846(1998). RN [3] RP NUCLEOTIDE SEQUENCE [GENOMIC DNA], AND VARIANTS LYS-70 AND HIS-295. RG SeattleSNPs variation discovery resource; RL Submitted (OCT-2001) to the EMBL/GenBank/DDBJ databases. RN [4] RP NUCLEOTIDE SEQUENCE [GENOMIC DNA]. RG NHLBI resequencing and genotyping service (RS&G); RL Submitted (FEB-2007) to the EMBL/GenBank/DDBJ databases. RN [5] RP NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]. RX PubMed=15057823; DOI=10.1038/nature02379; RA Dunham A., Matthews L.H., Burton J., Ashurst J.L., Howe K.L., RA Ashcroft K.J., Beare D.M., Burford D.C., Hunt S.E., Griffiths-Jones S., RA Jones M.C., Keenan S.J., Oliver K., Scott C.E., Ainscough R., Almeida J.P., RA Ambrose K.D., Andrews D.T., Ashwell R.I.S., Babbage A.K., Bagguley C.L., RA Bailey J., Bannerjee R., Barlow K.F., Bates K., Beasley H., Bird C.P., RA Bray-Allen S., Brown A.J., Brown J.Y., Burrill W., Carder C., Carter N.P., RA Chapman J.C., Clamp M.E., Clark S.Y., Clarke G., Clee C.M., Clegg S.C., RA Cobley V., Collins J.E., Corby N., Coville G.J., Deloukas P., Dhami P., RA Dunham I., Dunn M., Earthrowl M.E., Ellington A.G., Faulkner L., RA Frankish A.G., Frankland J., French L., Garner P., Garnett J., RA Gilbert J.G.R., Gilson C.J., Ghori J., Grafham D.V., Gribble S.M., RA Griffiths C., Hall R.E., Hammond S., Harley J.L., Hart E.A., Heath P.D., RA Howden P.J., Huckle E.J., Hunt P.J., Hunt A.R., Johnson C., Johnson D., RA Kay M., Kimberley A.M., King A., Laird G.K., Langford C.J., Lawlor S., RA Leongamornlert D.A., Lloyd D.M., Lloyd C., Loveland J.E., Lovell J., RA Martin S., Mashreghi-Mohammadi M., McLaren S.J., McMurray A., Milne S., RA Moore M.J.F., Nickerson T., Palmer S.A., Pearce A.V., Peck A.I., Pelan S., RA Phillimore B., Porter K.M., Rice C.M., Searle S., Sehra H.K., Shownkeen R., RA Skuce C.D., Smith M., Steward C.A., Sycamore N., Tester J., Thomas D.W., RA Tracey A., Tromans A., Tubby B., Wall M., Wallis J.M., West A.P., RA Whitehead S.L., Willey D.L., Wilming L., Wray P.W., Wright M.W., Young L., RA Coulson A., Durbin R.M., Hubbard T., Sulston J.E., Beck S., Bentley D.R., RA Rogers J., Ross M.T.; RT "The DNA sequence and analysis of human chromosome 13."; RL Nature 428:522-528(2004). RN [6] RP NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]. RA Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M., RA Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J., RA Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S., RA Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H., RA Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K., RA Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D., RA Hunkapiller M.W., Myers E.W., Venter J.C.; RL Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases. RN [7] RP NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1). RX PubMed=15489334; DOI=10.1101/gr.2596504; RG The MGC Project Team; RT "The status, quality, and expansion of the NIH full-length cDNA project: RT the Mammalian Gene Collection (MGC)."; RL Genome Res. 14:2121-2127(2004). RN [8] RP NUCLEOTIDE SEQUENCE [MRNA] OF 81-400, AND PROTEIN SEQUENCE OF 63-103. RX PubMed=2403355; DOI=10.1016/0006-291x(90)91197-z; RA Sejima H., Hayashi T., Deyashiki Y., Nishioka J., Suzuki K.; RT "Primary structure of vitamin K-dependent human protein Z."; RL Biochem. Biophys. Res. Commun. 171:661-668(1990). RN [9] RP GLYCOSYLATION AT SER-93, AND STRUCTURE OF CARBOHYDRATE ON SER-93. RX PubMed=2511201; DOI=10.1016/s0021-9258(19)47065-8; RA Nishimura H., Kawabata S., Kisiel W., Hase S., Ikenaka T., Takao T., RA Shimonishi Y., Iwanaga S.; RT "Identification of a disaccharide (Xyl-Glc) and a trisaccharide (Xyl2-Glc) RT O-glycosidically linked to a serine residue in the first epidermal growth RT factor-like domain of human factors VII and IX and protein Z and bovine RT protein Z."; RL J. Biol. Chem. 264:20320-20325(1989). RN [10] RP GLYCOSYLATION AT SER-93, AND STRUCTURE OF CARBOHYDRATE ON SER-93. RX PubMed=2129367; DOI=10.1007/978-1-4615-3806-6_12; RA Iwanaga S., Nishimura H., Kawabata S., Kisiel W., Hase S., Ikenaka T.; RT "A new trisaccharide sugar chain linked to a serine residue in the first RT EGF-like domain of clotting factors VII and IX and protein Z."; RL Adv. Exp. Med. Biol. 281:121-131(1990). RN [11] RP X-RAY CRYSTALLOGRAPHY (2.3 ANGSTROMS) OF 125-400 IN COMPLEX WITH SERPINA10, RP GLYCOSYLATION AT ASN-233, DISULFIDE BONDS, AND SUBUNIT. RX PubMed=19528533; DOI=10.1182/blood-2009-04-210021; RA Wei Z., Yan Y., Carrell R.W., Zhou A.; RT "Crystal structure of protein Z-dependent inhibitor complex shows how RT protein Z functions as a cofactor in the membrane inhibition of factor X."; RL Blood 114:3662-3667(2009). RN [12] RP X-RAY CRYSTALLOGRAPHY (3.26 ANGSTROMS) OF 84-400 IN COMPLEX WITH SERPINA10, RP GLYCOSYLATION AT ASN-99; ASN-225; ASN-233 AND ASN-332, DISULFIDE BONDS, AND RP SUBUNIT. RX PubMed=20427285; DOI=10.1074/jbc.m110.112748; RA Huang X., Dementiev A., Olson S.T., Gettins P.G.; RT "Basis for the specificity and activation of the serpin protein Z-dependent RT proteinase inhibitor (ZPI) as an inhibitor of membrane-associated factor RT Xa."; RL J. Biol. Chem. 285:20399-20409(2010). CC -!- FUNCTION: Appears to assist hemostasis by binding thrombin and CC promoting its association with phospholipid vesicles. Inhibits activity CC of the coagulation protease factor Xa in the presence of SERPINA10, CC calcium and phospholipids. CC -!- SUBUNIT: Interacts with SERPINA10. {ECO:0000269|PubMed:19528533, CC ECO:0000269|PubMed:20427285}. CC -!- INTERACTION: CC P22891; Q9UK55: SERPINA10; NbExp=7; IntAct=EBI-22220337, EBI-3941758; CC -!- SUBCELLULAR LOCATION: Secreted. CC -!- ALTERNATIVE PRODUCTS: CC Event=Alternative splicing; Named isoforms=2; CC Name=1; CC IsoId=P22891-1; Sequence=Displayed; CC Name=2; CC IsoId=P22891-2; Sequence=VSP_005415; CC -!- TISSUE SPECIFICITY: Plasma. CC -!- PTM: The iron and 2-oxoglutarate dependent 3-hydroxylation of aspartate CC and asparagine is (R) stereospecific within EGF domains. {ECO:0000250}. CC -!- SIMILARITY: Belongs to the peptidase S1 family. {ECO:0000255|PROSITE- CC ProRule:PRU00274}. CC -!- CAUTION: Although related to peptidase S1 family vitamin K-dependent CC clotting factors, it has lost two of the essential catalytic residues CC and therefore lacks protease activity. {ECO:0000305}. CC -!- WEB RESOURCE: Name=SeattleSNPs; CC URL="http://pga.gs.washington.edu/data/proz/"; CC --------------------------------------------------------------------------- CC Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms CC Distributed under the Creative Commons Attribution (CC BY 4.0) License CC --------------------------------------------------------------------------- DR EMBL; M55670; AAA36500.1; -; mRNA. DR EMBL; M55671; AAA36501.1; -; mRNA. DR EMBL; AB033749; BAA85763.1; -; Genomic_DNA. DR EMBL; AB033749; BAA85764.1; -; Genomic_DNA. DR EMBL; AF440358; AAL27631.1; -; Genomic_DNA. DR EMBL; EF445049; ACA06105.1; -; Genomic_DNA. DR EMBL; AL137002; -; NOT_ANNOTATED_CDS; Genomic_DNA. DR EMBL; CH471085; EAX09186.1; -; Genomic_DNA. DR EMBL; CH471085; EAX09187.1; -; Genomic_DNA. DR EMBL; BC074906; AAH74906.1; -; mRNA. DR EMBL; BC074907; AAH74907.1; -; mRNA. DR EMBL; M59303; AAA36499.1; -; mRNA. DR CCDS; CCDS58300.1; -. [P22891-2] DR CCDS; CCDS9531.1; -. [P22891-1] DR PIR; A36244; KXHUZ. DR RefSeq; NP_001243063.1; NM_001256134.1. [P22891-2] DR RefSeq; NP_003882.1; NM_003891.2. [P22891-1] DR PDB; 3F1S; X-ray; 2.30 A; B=125-400. DR PDB; 3H5C; X-ray; 3.26 A; B=84-400. DR PDBsum; 3F1S; -. DR PDBsum; 3H5C; -. DR AlphaFoldDB; P22891; -. DR SMR; P22891; -. DR BioGRID; 114382; 84. DR IntAct; P22891; 32. DR STRING; 9606.ENSP00000344458; -. DR MEROPS; S01.979; -. DR GlyConnect; 621; 1 O-Glc glycan, 1 O-Linked glycan. DR GlyCosmos; P22891; 6 sites, 2 glycans. DR GlyGen; P22891; 7 sites, 2 O-linked glycans (1 site). DR iPTMnet; P22891; -. DR PhosphoSitePlus; P22891; -. DR BioMuta; PROZ; -. DR DMDM; 131092; -. DR CPTAC; non-CPTAC-2706; -. DR jPOST; P22891; -. DR MassIVE; P22891; -. DR PaxDb; 9606-ENSP00000344458; -. DR PeptideAtlas; P22891; -. DR ProteomicsDB; 54045; -. [P22891-1] DR ProteomicsDB; 54046; -. [P22891-2] DR Antibodypedia; 25847; 253 antibodies from 27 providers. DR DNASU; 8858; -. DR Ensembl; ENST00000342783.5; ENSP00000344458.4; ENSG00000126231.15. [P22891-2] DR Ensembl; ENST00000375547.7; ENSP00000364697.2; ENSG00000126231.15. [P22891-1] DR GeneID; 8858; -. DR KEGG; hsa:8858; -. DR MANE-Select; ENST00000375547.7; ENSP00000364697.2; NM_003891.3; NP_003882.1. DR UCSC; uc001vta.3; human. [P22891-1] DR AGR; HGNC:9460; -. DR CTD; 8858; -. DR DisGeNET; 8858; -. DR GeneCards; PROZ; -. DR HGNC; HGNC:9460; PROZ. DR HPA; ENSG00000126231; Tissue enriched (liver). DR MalaCards; PROZ; -. DR MIM; 176895; gene. DR neXtProt; NX_P22891; -. DR OpenTargets; ENSG00000126231; -. DR Orphanet; 329217; Cerebral sinovenous thrombosis. DR Orphanet; 64738; NON RARE IN EUROPE: Non rare thrombophilia. DR PharmGKB; PA33813; -. DR VEuPathDB; HostDB:ENSG00000126231; -. DR eggNOG; KOG3627; Eukaryota. DR GeneTree; ENSGT00940000154505; -. DR HOGENOM; CLU_006842_19_5_1; -. DR InParanoid; P22891; -. DR OMA; NTARYMI; -. DR OrthoDB; 5172471at2759; -. DR PhylomeDB; P22891; -. DR TreeFam; TF327329; -. DR PathwayCommons; P22891; -. DR Reactome; R-HSA-159740; Gamma-carboxylation of protein precursors. DR Reactome; R-HSA-159763; Transport of gamma-carboxylated protein precursors from the endoplasmic reticulum to the Golgi apparatus. DR Reactome; R-HSA-159782; Removal of aminoterminal propeptides from gamma-carboxylated proteins. DR SignaLink; P22891; -. DR SIGNOR; P22891; -. DR BioGRID-ORCS; 8858; 11 hits in 1145 CRISPR screens. DR ChiTaRS; PROZ; human. DR EvolutionaryTrace; P22891; -. DR GenomeRNAi; 8858; -. DR Pharos; P22891; Tbio. DR PRO; PR:P22891; -. DR Proteomes; UP000005640; Chromosome 13. DR RNAct; P22891; Protein. DR Bgee; ENSG00000126231; Expressed in right lobe of liver and 99 other cell types or tissues. DR GO; GO:0005788; C:endoplasmic reticulum lumen; TAS:Reactome. DR GO; GO:0070062; C:extracellular exosome; HDA:UniProtKB. DR GO; GO:0005615; C:extracellular space; IBA:GO_Central. DR GO; GO:0005796; C:Golgi lumen; TAS:Reactome. DR GO; GO:0005509; F:calcium ion binding; IEA:InterPro. DR GO; GO:0004252; F:serine-type endopeptidase activity; IEA:InterPro. DR GO; GO:0007596; P:blood coagulation; IBA:GO_Central. DR GO; GO:0006508; P:proteolysis; IEA:InterPro. DR CDD; cd00054; EGF_CA; 1. DR Gene3D; 4.10.740.10; Coagulation Factor IX; 1. DR Gene3D; 2.10.25.10; Laminin; 2. DR Gene3D; 2.40.10.10; Trypsin-like serine proteases; 2. DR InterPro; IPR017857; Coagulation_fac-like_Gla_dom. DR InterPro; IPR001881; EGF-like_Ca-bd_dom. DR InterPro; IPR000742; EGF-like_dom. DR InterPro; IPR000152; EGF-type_Asp/Asn_hydroxyl_site. DR InterPro; IPR035972; GLA-like_dom_SF. DR InterPro; IPR000294; GLA_domain. DR InterPro; IPR012224; Pept_S1A_FX. DR InterPro; IPR009003; Peptidase_S1_PA. DR InterPro; IPR043504; Peptidase_S1_PA_chymotrypsin. DR InterPro; IPR001254; Trypsin_dom. DR PANTHER; PTHR24278; COAGULATION FACTOR; 1. DR PANTHER; PTHR24278:SF20; VITAMIN K-DEPENDENT PROTEIN Z; 1. DR Pfam; PF00008; EGF; 1. DR Pfam; PF14670; FXa_inhibition; 1. DR Pfam; PF00594; Gla; 1. DR Pfam; PF00089; Trypsin; 1. DR PIRSF; PIRSF001143; Factor_X; 1. DR PRINTS; PR00001; GLABLOOD. DR SMART; SM00181; EGF; 2. DR SMART; SM00179; EGF_CA; 2. DR SMART; SM00069; GLA; 1. DR SMART; SM00020; Tryp_SPc; 1. DR SUPFAM; SSF57196; EGF/Laminin; 1. DR SUPFAM; SSF57630; GLA-domain; 1. DR SUPFAM; SSF50494; Trypsin-like serine proteases; 1. DR PROSITE; PS00010; ASX_HYDROXYL; 1. DR PROSITE; PS00022; EGF_1; 1. DR PROSITE; PS01186; EGF_2; 2. DR PROSITE; PS50026; EGF_3; 1. DR PROSITE; PS00011; GLA_1; 1. DR PROSITE; PS50998; GLA_2; 1. DR PROSITE; PS50240; TRYPSIN_DOM; 1. DR Genevisible; P22891; HS. PE 1: Evidence at protein level; KW 3D-structure; Alternative splicing; Blood coagulation; Calcium; KW Cleavage on pair of basic residues; Direct protein sequencing; KW Disulfide bond; EGF-like domain; Gamma-carboxyglutamic acid; Glycoprotein; KW Hemostasis; Hydroxylation; Reference proteome; Repeat; Secreted; KW Serine protease homolog; Signal. FT SIGNAL 1..23 FT PROPEP 24..40 FT /id="PRO_0000028488" FT CHAIN 41..400 FT /note="Vitamin K-dependent protein Z" FT /evidence="ECO:0000269|PubMed:2244898" FT /id="PRO_0000028489" FT DOMAIN 41..86 FT /note="Gla" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00463" FT DOMAIN 87..123 FT /note="EGF-like 1" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00076" FT DOMAIN 125..166 FT /note="EGF-like 2" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00076" FT DOMAIN 175..400 FT /note="Peptidase S1" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00274" FT MOD_RES 47 FT /note="4-carboxyglutamate" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00463, FT ECO:0000269|PubMed:2244898" FT MOD_RES 48 FT /note="4-carboxyglutamate" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00463, FT ECO:0000269|PubMed:2244898" FT MOD_RES 51 FT /note="4-carboxyglutamate" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00463, FT ECO:0000269|PubMed:2244898" FT MOD_RES 55 FT /note="4-carboxyglutamate" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00463, FT ECO:0000269|PubMed:2244898" FT MOD_RES 57 FT /note="4-carboxyglutamate" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00463, FT ECO:0000269|PubMed:2244898" FT MOD_RES 60 FT /note="4-carboxyglutamate" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00463, FT ECO:0000269|PubMed:2244898" FT MOD_RES 61 FT /note="4-carboxyglutamate" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00463, FT ECO:0000269|PubMed:2244898" FT MOD_RES 66 FT /note="4-carboxyglutamate" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00463, FT ECO:0000269|PubMed:2244898" FT MOD_RES 67 FT /note="4-carboxyglutamate" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00463, FT ECO:0000269|PubMed:2244898" FT MOD_RES 70 FT /note="4-carboxyglutamate" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00463, FT ECO:0000269|PubMed:2244898" FT MOD_RES 73 FT /note="4-carboxyglutamate" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00463, FT ECO:0000269|PubMed:2244898" FT MOD_RES 75 FT /note="4-carboxyglutamate" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00463, FT ECO:0000269|PubMed:2244898" FT MOD_RES 80 FT /note="4-carboxyglutamate" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00463, FT ECO:0000269|PubMed:2244898" FT MOD_RES 104 FT /note="(3R)-3-hydroxyaspartate" FT /evidence="ECO:0000250" FT CARBOHYD 93 FT /note="O-linked (Glc...) serine" FT /evidence="ECO:0000269|PubMed:2129367, FT ECO:0000269|PubMed:2511201" FT CARBOHYD 99 FT /note="N-linked (GlcNAc...) asparagine" FT /evidence="ECO:0000269|PubMed:20427285" FT CARBOHYD 225 FT /note="N-linked (GlcNAc...) asparagine" FT /evidence="ECO:0000269|PubMed:20427285" FT CARBOHYD 233 FT /note="N-linked (GlcNAc...) asparagine" FT /evidence="ECO:0000269|PubMed:19528533, FT ECO:0000269|PubMed:20427285" FT CARBOHYD 306 FT /note="N-linked (GlcNAc...) asparagine" FT /evidence="ECO:0000255" FT CARBOHYD 332 FT /note="N-linked (GlcNAc...) asparagine" FT /evidence="ECO:0000269|PubMed:20427285" FT DISULFID 58..63 FT /evidence="ECO:0000250" FT DISULFID 91..102 FT DISULFID 96..111 FT DISULFID 113..122 FT DISULFID 129..141 FT DISULFID 137..150 FT DISULFID 152..165 FT DISULFID 203..219 FT DISULFID 327..341 FT VAR_SEQ 24 FT /note="V -> ATSLKERHGLHSDSACTGVQESL (in isoform 2)" FT /evidence="ECO:0000305" FT /id="VSP_005415" FT VARIANT 70 FT /note="E -> K (in dbSNP:rs3024778)" FT /evidence="ECO:0000269|Ref.3" FT /id="VAR_013124" FT VARIANT 295 FT /note="R -> H (in dbSNP:rs3024772)" FT /evidence="ECO:0000269|Ref.3" FT /id="VAR_013125" FT TURN 97..99 FT /evidence="ECO:0007829|PDB:3H5C" FT STRAND 106..108 FT /evidence="ECO:0007829|PDB:3H5C" FT STRAND 114..116 FT /evidence="ECO:0007829|PDB:3H5C" FT STRAND 119..122 FT /evidence="ECO:0007829|PDB:3H5C" FT STRAND 126..128 FT /evidence="ECO:0007829|PDB:3H5C" FT STRAND 134..136 FT /evidence="ECO:0007829|PDB:3F1S" FT STRAND 138..140 FT /evidence="ECO:0007829|PDB:3F1S" FT STRAND 145..147 FT /evidence="ECO:0007829|PDB:3H5C" FT STRAND 149..151 FT /evidence="ECO:0007829|PDB:3H5C" FT STRAND 156..158 FT /evidence="ECO:0007829|PDB:3F1S" FT STRAND 165..167 FT /evidence="ECO:0007829|PDB:3F1S" FT STRAND 191..195 FT /evidence="ECO:0007829|PDB:3F1S" FT STRAND 197..199 FT /evidence="ECO:0007829|PDB:3H5C" FT STRAND 201..209 FT /evidence="ECO:0007829|PDB:3F1S" FT STRAND 212..215 FT /evidence="ECO:0007829|PDB:3F1S" FT HELIX 217..220 FT /evidence="ECO:0007829|PDB:3F1S" FT STRAND 227..230 FT /evidence="ECO:0007829|PDB:3F1S" FT STRAND 240..249 FT /evidence="ECO:0007829|PDB:3F1S" FT TURN 255..258 FT /evidence="ECO:0007829|PDB:3F1S" FT STRAND 263..269 FT /evidence="ECO:0007829|PDB:3F1S" FT TURN 273..276 FT /evidence="ECO:0007829|PDB:3F1S" FT HELIX 285..290 FT /evidence="ECO:0007829|PDB:3F1S" FT TURN 291..295 FT /evidence="ECO:0007829|PDB:3F1S" FT STRAND 298..302 FT /evidence="ECO:0007829|PDB:3F1S" FT STRAND 309..311 FT /evidence="ECO:0007829|PDB:3H5C" FT STRAND 315..322 FT /evidence="ECO:0007829|PDB:3F1S" FT HELIX 324..331 FT /evidence="ECO:0007829|PDB:3F1S" FT STRAND 339..343 FT /evidence="ECO:0007829|PDB:3F1S" FT HELIX 348..350 FT /evidence="ECO:0007829|PDB:3F1S" FT STRAND 356..360 FT /evidence="ECO:0007829|PDB:3F1S" FT STRAND 365..371 FT /evidence="ECO:0007829|PDB:3F1S" FT HELIX 376..378 FT /evidence="ECO:0007829|PDB:3F1S" FT STRAND 380..387 FT /evidence="ECO:0007829|PDB:3F1S" FT HELIX 388..391 FT /evidence="ECO:0007829|PDB:3F1S" FT HELIX 392..399 FT /evidence="ECO:0007829|PDB:3F1S" SQ SEQUENCE 400 AA; 44744 MW; 7EBD2DCC48860268 CRC64; MAGCVPLLQG LVLVLALHRV EPSVFLPASK ANDVLVRWKR AGSYLLEELF EGNLEKECYE EICVYEEARE VFENEVVTDE FWRRYKGGSP CISQPCLHNG SCQDSIWGYT CTCSPGYEGS NCELAKNECH PERTDGCQHF CLPGQESYTC SCAQGYRLGE DHKQCVPHDQ CACGVLTSEK RAPDLQDLPW QVKLTNSEGK DFCGGVIIRE NFVLTTAKCS LLHRNITVKT YFNRTSQDPL MIKITHVHVH MRYDADAGEN DLSLLELEWP IQCPGAGLPV CTPEKDFAEH LLIPRTRGLL SGWARNGTDL GNSLTTRPVT LVEGEECGQV LNVTVTTRTY CERSSVAAMH WMDGSVVTRE HRGSWFLTGV LGSQPVGGQA HMVLVTKVSR YSLWFKQIMN //